Similar to their counterparts in the brain, retinal microglia have also been implicated in a number of retinal degenerative, inflammatory, and vascular diseases.
7 8 9 Activated retinal microglia have been found in human tissue histopathologic specimens of retinal disease where pathologic changes are found.
10 11 12 Abnormal accumulation and altered morphologies of retinal microglia have also been found in animal models of retinal disease, including retinal detachment,
9 retinitis pigmentosa
8 13 age-related macular degeneration,
14 15 and diabetic retinopathy.
16 In the latter, studies in mouse models
16 and human disease
12 demonstrate that morphologic changes in retinal microglia occur early in disease progression, suggesting that these may have a inductive role in causing pathologic neuronal and vascular changes. Numerous studies have demonstrated that microglia, in general, display a multifaceted array of structural phenotypes that can change markedly, depending on the tissue context.
17 18 These phenotype changes include alterations in cellular morphology, tissue distribution, migratory characteristics, and changes in process structure. These structural phenotypes are thought to reflect different functional modes, enabling microglia to effect different changes in the surrounding tissue.
2 In the retina, characterizations of these microglial phenotypes under normal and disease conditions, and how they reflect on changing microglia function, are not well understood. In addition, how various therapeutic interventions in retinal disorders may cause changes in microglia physiology is unknown.